Acquisition by Sirosh Joseph of 45180 shares of Absci Corp at 7.19 subject to Rule 16b-3
ABSI Stock | USD 4.02 0.81 25.23% |
Under 50% of Absci Corp's traders are presently thinking to get in. The analysis of the overall investor sentiment regarding Absci Corp suggests that some traders are interested. Absci Corp's investing sentiment shows overall attitude of investors towards Absci Corp.
Absci |
Filed transaction by Absci Corp Director. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Absci Corp's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Absci Corp's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Absci Corp Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Absci Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Absci Corp Fundamental Analysis
We analyze Absci Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Absci Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Absci Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Absci Corp is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Absci Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Absci Corp stock to make a market-neutral strategy. Peer analysis of Absci Corp could also be used in its relative valuation, which is a method of valuing Absci Corp by comparing valuation metrics with similar companies.
Peers
Absci Corp Related Equities
ELEV | Elevation Oncology | 15.38 | ||||
INZY | Inozyme Pharma | 5.74 | ||||
ZURA | Zura Bio | 0.72 | ||||
HEPA | Hepion Pharmaceuticals | 0.85 | ||||
RXRX | Recursion Pharmaceuticals | 1.34 | ||||
DAWN | Day One | 2.66 | ||||
ABOS | Acumen Pharmaceuticals | 3.21 | ||||
DTIL | Precision BioSciences | 3.36 | ||||
XFOR | X4 Pharmaceuticals | 3.95 | ||||
CRBU | Caribou Biosciences | 5.14 | ||||
RLAY | Relay Therapeutics | 5.74 | ||||
SANA | Sana Biotechnology | 6.42 | ||||
AFMD | Affimed NV | 9.05 |
Complementary Tools for Absci Stock analysis
When running Absci Corp's price analysis, check to measure Absci Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Absci Corp is operating at the current time. Most of Absci Corp's value examination focuses on studying past and present price action to predict the probability of Absci Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Absci Corp's price. Additionally, you may evaluate how the addition of Absci Corp to your portfolios can decrease your overall portfolio volatility.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |